S'abonner

Health care worker perceptions toward computerized clinical decision support tools for Clostridium difficile infection reduction: A qualitative study at 2 hospitals - 27/09/18

Doi : 10.1016/j.ajic.2018.04.204 
Natalia Blanco, PhD, MPH a, * , Lyndsay M. O'Hara, PhD, MPH a, Gwen L. Robinson, MPH a, Jeanine Brown, MSN a, Emily Heil, PharmD a, b, Clayton H. Brown, PhD, MS a, Brian D. Stump, PharmD c, Bryant W. Sigler, MS c, Anusha Belani, MD c, Heidi L. Miller, RN d, Amber N. Chiplinski, PharmD d, Rebecca Perlmutter, MPH e, Lucy Wilson, MD, MS e, Daniel J. Morgan, MD, MS a, f, Surbhi Leekha, MBBS, MPH a
a Department of Epidemiology and Public Health, University of Maryland School of Medicine, Baltimore, MD 
b Department of Pharmacy Practice and Science, University of Maryland School of Pharmacy, Baltimore, MD 
c Frederick Memorial Hospital, Frederick, MD 
d Meritus Health, Hagerstown, MD 
e Emerging Infections Program, Maryland Department of Health, Baltimore, MD 
f VA Maryland Healthcare System, Baltimore, MD 

*Address correspondence to Natalia Blanco, PhD, MPH, University of Maryland School of Medicine, 10 S Pine St, Ste 360F, Baltimore, MD 21201. (N. Blanco).University of Maryland School of Medicine10 S Pine St, Ste 360FBaltimoreMD21201

Highlights

The impact of an electronic Clostridium difficile infection reduction bundle was assessed.
Gaps in knowledge and communication between health care workers were observed.
A perceived loss of autonomy and clinical judgment was identified.
Standardization and automation were perceived benefits.
End users agreed the tools could help them to improve the quality of patient care.

Le texte complet de cet article est disponible en PDF.

Abstract

Background

Clostridium difficile infection (CDI) is associated with significant morbidity and mortality. Computerized clinical decision support (CCDS) tools can aid process improvement in infection prevention and antibiotic stewardship, but implementation and health care workers (HCWs) uptake of these tools is often variable. The objective of this study was to describe HCWs' perceptions of barriers and facilitators related to uptake of CCDS tools as part of a CDI reduction bundle.

Methods

We conducted a qualitative study among HCWs at 2 acute care hospitals in Maryland. Semi-structured interviews and structured surveys were completed by HCWs to evaluate their perception to CCDS tools at 2 different stages: predevelopment and preimplementation. Emergent themes and patterns in the data were identified and condensed.

Results

Gaps in CDI-related knowledge and in communication between HCWs were identified throughout the evaluation. HCWs agreed on the potential of the tools to improve CDI diagnosis, prevention, and control. An important barrier for uptake was the perceived loss of autonomy and clinical judgment, whereas standardization and error reduction were perceived advantages.

Conclusions

These observations shaped the development and implementation of the CDI reduction bundle. Qualitative findings can provide valuable contextual information during the development stages of CCDS tools in infection prevention and antibiotic stewardship.

Le texte complet de cet article est disponible en PDF.

Key Words : Clostridium difficile infection, computerized clinical decision support, antibiotics, proton-pump inhibitors


Plan


 Funding/support: Supported by the Centers for Disease Control and Prevention through a Broad Agency Announcement (contract no. 200-2016-91943).
 Conflicts of interest: N.B. reports grants from Centers for Disease Control and Prevention, during the conduct of the study; S.L. reports grants from Centers for Disease Control and Prevention, during the conduct of the study; D.J.M. reports grants from CDC, NIH, AHRQ, VA HSRD, IDSA, other from ASM, Lown and SHEA for expenses to organize or present at national meetings,other from Springer Inc, outside the submitted work; C.B. reports grants from Centers for Disease Control, during the conduct of the study; G.L.R. reports grants from Centers for Disease Control, during the conduct of the study; J.B. reports grants from Centers for Disease Control, during the conduct of the study; L.M.O reports grants from Centers for Disease Control and Prevention, during the conduct of the study; E.H. reports grants from ALK-ABELLO, outside the submitted work; there are no other conflicts to disclose.


© 2018  Publié par Elsevier Masson SAS.
Ajouter à ma bibliothèque Retirer de ma bibliothèque Imprimer
Export

    Export citations

  • Fichier

  • Contenu

Vol 46 - N° 10

P. 1160-1166 - octobre 2018 Retour au numéro
Article précédent Article précédent
  • A microbiological study to investigate the carriage and transmission-potential of Clostridium difficile spores on single-use and reusable sharps containers
  • Terry Grimmond, Anu Neelakanta, Barbara Miller, Asif Saiyed, Pam Gill, Jennifer Cadnum, Russell Olmsted, Curtis Donskey, Kimberly Pate, Katherine Miller
| Article suivant Article suivant
  • Enacting high reliability principles while caring for people with Ebola Virus Disease
  • Bonnie Mowinski Jennings, Katherine A. Yeager, Nancye R. Feistritzer, Mary M. Gullatte, Kristy K. Martyn

Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.

Déjà abonné à cette revue ?

Elsevier s'engage à rendre ses eBooks accessibles et à se conformer aux lois applicables. Compte tenu de notre vaste bibliothèque de titres, il existe des cas où rendre un livre électronique entièrement accessible présente des défis uniques et l'inclusion de fonctionnalités complètes pourrait transformer sa nature au point de ne plus servir son objectif principal ou d'entraîner un fardeau disproportionné pour l'éditeur. Par conséquent, l'accessibilité de cet eBook peut être limitée. Voir plus

Mon compte


Plateformes Elsevier Masson

Déclaration CNIL

EM-CONSULTE.COM est déclaré à la CNIL, déclaration n° 1286925.

En application de la loi nº78-17 du 6 janvier 1978 relative à l'informatique, aux fichiers et aux libertés, vous disposez des droits d'opposition (art.26 de la loi), d'accès (art.34 à 38 de la loi), et de rectification (art.36 de la loi) des données vous concernant. Ainsi, vous pouvez exiger que soient rectifiées, complétées, clarifiées, mises à jour ou effacées les informations vous concernant qui sont inexactes, incomplètes, équivoques, périmées ou dont la collecte ou l'utilisation ou la conservation est interdite.
Les informations personnelles concernant les visiteurs de notre site, y compris leur identité, sont confidentielles.
Le responsable du site s'engage sur l'honneur à respecter les conditions légales de confidentialité applicables en France et à ne pas divulguer ces informations à des tiers.


Tout le contenu de ce site: Copyright © 2026 Elsevier, ses concédants de licence et ses contributeurs. Tout les droits sont réservés, y compris ceux relatifs à l'exploration de textes et de données, a la formation en IA et aux technologies similaires. Pour tout contenu en libre accès, les conditions de licence Creative Commons s'appliquent.